Analyst Research: Orexigen Therapeutics Inc (OREX.OQ)

OREX.OQ on NASDAQ Stock Exchange Global Select Market

7.55USD
3:32pm EDT
Price Change (% chg)

$0.01 (+0.20%)
Prev Close
$7.54
Open
$7.51
Day's High
$7.66
Day's Low
$7.46
Volume
160,108
Avg. Vol
337,439
52-wk High
$7.84
52-wk Low
$3.77

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - OREXIGEN THERAPEUTICS INC (OREX-O) 6:20am EDT Thomson Reuters Stock Report 11 25.00
ValuEngine Detailed Valuation Report for OREX 31 Jul 2013 ValuEngine, Inc. 11 25.00
Orexigen Therapeutics 27 Jul 2013 S&P Capital IQ Quantitative Report 6 69.00
OREXIGEN THERAPEUTICS INC (OREX) 12-months forecast 26 Jul 2013 Pechala's Reports 1 15.00
Orexigen Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 26 Jul 2013 Reuters Investment Profile 12 20.00
OREXIGEN THERAP (OREX) Zacks Company Snapshot 26 Jul 2013 Zacks Investment Research Inc. 1 12.00
OREXIGEN THERAP (OREX) Zacks Company Snapshot 25 Jul 2013 Zacks Investment Research Inc. 1 12.00
OREXIGEN THERAP (OREX) Zacks Company Snapshot 24 Jul 2013 Zacks Investment Research Inc. 1 12.00
TheStreet.com Ratings Stock Report For: OREXIGEN THERAPEUTICS INC (OREX) 20 Jul 2013 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

Eckard Weber

2009 Independent Chairman of the Board

Michael Narachi

53 2009 President, Chief Executive Officer, Director

Joseph Hagan

43 2011 Acting Chief Financial Officer, Treasurer, Chief Business Officer

Heather Turner

39 2010 Senior Vice President, General Counsel, Secretary

Preston Klassen

43 2009 Head of Global Contrave Program, Senior Vice President - Product Development
Search Stocks